English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Press release submission | Oct 11, 2018

THE LEUKEMIA AND LYMPHOMA SOCIETY: Receives Significant Gift to Support Promising Young Scientists

+ Technology/Innovation
Press release submission | Oct 11, 2018

MEI PHARMA INC.: MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies

+ Technology/Innovation
Press release submission | Oct 4, 2018

SWISSLOG HEALTHCARE SOLUTIONS: Skilled Nursing Facilities Seek Solutions to Address Quality as Interest in Post-Acute Care Transitions is on the Rise

+ Technology/Innovation
Press release submission | Oct 4, 2018

PRELUDE FERTILITY: Prelude Fertility and NYU Langone Health Announce Partnership Targeting Expansion of Patient Care

Press release submission | Sep 27, 2018

MONTEFIORE HEALTH SYSTEM: Montefiore Earns Highest Status in Stroke Care

+ Technology/Innovation
Press release submission | Sep 27, 2018

ABBOTT CORPORATION: Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance

+ Community
Press release submission | Sep 23, 2018

ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families

Press release submission | Sep 23, 2018

ELI LILLY AND COMPANY: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 340
  • 341
  • 342
  • 343
  • 344
  • 345
  • 346
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily